Quick Answer
Senti Biosciences Holdings, Inc. reported Total Revenue of $22.0 thousand for fiscal year 2025.
Senti Biosciences Holdings, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $22.0K | — |
| 2024 | $0.00 | -100.0% |
| 2023 | $2.56M | -40.2% |
| 2022 | $4.29M | +55.2% |
| 2021 | $2.76M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | $0.00 | -100.0% | — |
| June 30, 2024 | $0.00 | -100.0% | — |
| March 31, 2024 | $0.00 | -100.0% | -100.0% |
| September 30, 2023 | $338.0K | -80.9% | -63.9% |
| June 30, 2023 | $937.0K | -31.0% | -27.1% |
| March 31, 2023 | $1.29M | +16.5% | -27.2% |
| September 30, 2022 | $1.77M | +60.1% | +30.0% |
| June 30, 2022 | $1.36M | +71.2% | +23.0% |
- Over the 2021–2025 period, Senti Biosciences Holdings, Inc.’s total revenue has declined by 99.2% (from $2.76 million to $22.0 thousand).
- The most recent figure is from Senti Biosciences Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: